By Indication

Cardiovascular Risk (Polygenic) Market Analysis

Cross-industry research covering Cardiovascular Risk (Polygenic) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering Cardiovascular Risk (Polygenic)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Polygenic risk scores for coronary artery disease and hypertension are validated in large biobank studies but adoption by DTC consumers remains limited by low genetic health literacy among the target population.

8%

Market Share

8.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments